15-58560910-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000236.3(LIPC):​c.1098A>G​(p.Thr366Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.975 in 1,530,340 control chromosomes in the GnomAD database, including 728,244 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.95 ( 68368 hom., cov: 32)
Exomes 𝑓: 0.98 ( 659876 hom. )

Consequence

LIPC
NM_000236.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.123

Publications

26 publications found
Variant links:
Genes affected
LIPC (HGNC:6619): (lipase C, hepatic type) Enables phospholipase A1 activity and triglyceride lipase activity. Involved in several processes, including lipid homeostasis; plasma lipoprotein particle remodeling; and triglyceride catabolic process. Located in extracellular space. Implicated in several diseases, including Alzheimer's disease; coronary artery disease; familial combined hyperlipidemia; peripheral vascular disease; and type 2 diabetes mellitus. Biomarker of hyperinsulinism; obesity; and type 1 diabetes mellitus. [provided by Alliance of Genome Resources, Apr 2022]
LIPC Gene-Disease associations (from GenCC):
  • hyperlipidemia due to hepatic triglyceride lipase deficiency
    Inheritance: AR, Unknown Classification: STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 15-58560910-A-G is Benign according to our data. Variant chr15-58560910-A-G is described in ClinVar as Benign. ClinVar VariationId is 316674.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.123 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.979 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LIPCNM_000236.3 linkc.1098A>G p.Thr366Thr synonymous_variant Exon 7 of 9 ENST00000299022.10 NP_000227.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LIPCENST00000299022.10 linkc.1098A>G p.Thr366Thr synonymous_variant Exon 7 of 9 1 NM_000236.3 ENSP00000299022.5

Frequencies

GnomAD3 genomes
AF:
0.946
AC:
143958
AN:
152152
Hom.:
68334
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.858
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.982
Gnomad ASJ
AF:
0.998
Gnomad EAS
AF:
0.936
Gnomad SAS
AF:
0.987
Gnomad FIN
AF:
0.947
Gnomad MID
AF:
0.984
Gnomad NFE
AF:
0.986
Gnomad OTH
AF:
0.966
GnomAD2 exomes
AF:
0.972
AC:
244309
AN:
251330
AF XY:
0.975
show subpopulations
Gnomad AFR exome
AF:
0.860
Gnomad AMR exome
AF:
0.991
Gnomad ASJ exome
AF:
0.997
Gnomad EAS exome
AF:
0.942
Gnomad FIN exome
AF:
0.949
Gnomad NFE exome
AF:
0.985
Gnomad OTH exome
AF:
0.981
GnomAD4 exome
AF:
0.978
AC:
1348031
AN:
1378070
Hom.:
659876
Cov.:
25
AF XY:
0.979
AC XY:
675895
AN XY:
690322
show subpopulations
African (AFR)
AF:
0.855
AC:
27192
AN:
31786
American (AMR)
AF:
0.990
AC:
44144
AN:
44606
Ashkenazi Jewish (ASJ)
AF:
0.998
AC:
25614
AN:
25672
East Asian (EAS)
AF:
0.910
AC:
35750
AN:
39266
South Asian (SAS)
AF:
0.987
AC:
83466
AN:
84564
European-Finnish (FIN)
AF:
0.948
AC:
50603
AN:
53390
Middle Eastern (MID)
AF:
0.987
AC:
5548
AN:
5620
European-Non Finnish (NFE)
AF:
0.985
AC:
1019566
AN:
1035578
Other (OTH)
AF:
0.975
AC:
56148
AN:
57588
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.420
Heterozygous variant carriers
0
1430
2860
4291
5721
7151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19594
39188
58782
78376
97970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.946
AC:
144044
AN:
152270
Hom.:
68368
Cov.:
32
AF XY:
0.946
AC XY:
70413
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.857
AC:
35612
AN:
41538
American (AMR)
AF:
0.982
AC:
15018
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.998
AC:
3466
AN:
3472
East Asian (EAS)
AF:
0.936
AC:
4848
AN:
5180
South Asian (SAS)
AF:
0.987
AC:
4763
AN:
4828
European-Finnish (FIN)
AF:
0.947
AC:
10039
AN:
10606
Middle Eastern (MID)
AF:
0.983
AC:
289
AN:
294
European-Non Finnish (NFE)
AF:
0.986
AC:
67051
AN:
68032
Other (OTH)
AF:
0.967
AC:
2046
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
372
744
1117
1489
1861
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.974
Hom.:
293067
Bravo
AF:
0.945
Asia WGS
AF:
0.962
AC:
3346
AN:
3478
EpiCase
AF:
0.987
EpiControl
AF:
0.987

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Hyperlipidemia due to hepatic triglyceride lipase deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.12
DANN
Benign
0.34
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3829461; hg19: chr15-58853109; COSMIC: COSV108154886; API